Cargando…
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
OBJECTIVES: Despite successful antiretroviral therapy, people living with HIV (PLWH) may show signs of premature/accentuated aging. We compared established biomarkers of aging in PLWH, appropriately chosen HIV-negative individuals, and blood donors, and explored factors associated with biological ag...
Autores principales: | De Francesco, Davide, Wit, Ferdinand W., Bürkle, Alexander, Oehlke, Sebastian, Kootstra, Neeltje A., Winston, Alan, Franceschi, Claudio, Garagnani, Paolo, Pirazzini, Chiara, Libert, Claude, Grune, Tilman, Weber, Daniela, Jansen, Eugène H.J.M., Sabin, Caroline A., Reiss, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319574/ https://www.ncbi.nlm.nih.gov/pubmed/30325781 http://dx.doi.org/10.1097/QAD.0000000000002063 |
Ejemplares similares
-
High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid
por: Booiman, Thijs, et al.
Publicado: (2017) -
Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls
por: Booiman, Thijs, et al.
Publicado: (2017) -
Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms
por: Mudra Rakshasa-Loots, Arish, et al.
Publicado: (2023) -
Monocyte and T Cell Immune Phenotypic Profiles Associated With Age Advancement Differ Between People With HIV, Lifestyle-Comparable Controls and Blood Donors
por: De Francesco, Davide, et al.
Publicado: (2020) -
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy
por: Pasternak, Alexander O, et al.
Publicado: (2021)